Regulators identify weaknesses in OTC derivatives markets

p9-lubke-gif

The over-the-counter derivatives market was criticised by two senior regulators at the International Swaps and Derivatives Association's annual general meeting in Beijing last month, with both identifying weaknesses they claim contributed to the financial crisis and which still need to be addressed.

Theo Lubke, senior vice-president at the Federal Reserve Bank of New York, identified six main problem areas in the OTC derivatives market. Meanwhile, Liu Mingkang, chairman of the China Banking

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: